December 2015
Lupin Receives FDA Approval for Generic Femhrt® Tablets
Date: December 28
Lupin Receives FDA Approval for Potassium Chloride Extended Release Capsules
Date: December 23
November 2015
Lupin Receives FDA Approvals for Generic Loestrin® Fe 1/20 and Loestrin®1.5/30 Tablets
Date: November 24
Lupin Appoints Thierry Volle as President - Europe, Middle-East & Africa (EMEA)
Date: November 5
Lupin receives FDA Approval for Generic Aricept® Tablets
Date: November 3
Lupin Receives FDA Approval for Generic Loestrin®24 Fe Tablets
Date: November 3
October 2015
Lupin Limited - Quarter II Results, FY2016
Date: October 27
Lupin Launches Generic PhosLo® in the US
Date: October 26
Lupin Appoints Martin Mercer as President of its Latin American Business
Date: October 26
Lupin Appoints Fabrice Egros as President of its Asia-Pacific Business
Date: October 23
Lupin and Boehringer Ingelheim Announce Strategic Co-marketing Agreement
Date: October 14
September 2015
Lupin launches first ever Duloxetine 40mg Delayed-Release Capsules in the US
Date: August 27
August 2015
Lupin receives FDA Approval for Generic Priloseci® Capsules
Date: August 27
Lupin receives FDA approval for Fenofibrate Tablets, 54 mg and 160 mg
Date: August 20
Lupin Announces New Center of Excellence for Inhalation Research in Florida
Date: August 7
July 2015
Lupin Acquires Specialty Product Portfolio in Germany
Date: July 24
Lupin Acquires GAVIS to Expand US Generic Business
Date: July 23
Lupin Limited - Quarter I Results, FY2016
Date: July 23
Lupin Acquires Biocom in Russia
Date: July 02
May 2015
Lupin Acquires Medqua-mica in Brazil
Date: May 13
Quarter IV and Annual Results, FY 2014-15
FY 2014-15 Net Sales up 13.6%, EBITDA up 23.7%, Net profit up 30.9%

Date: May 13
April 2015
Lupin Launches Zaxinei® in Canada
Date: April 20
Lupin Launches Generic Exforgei® Tablets in the US
Date: April 1
March 2015
Lupin and Rotary Join Hands to Combat Tuberculosis in Mumbai
Date: Mar 24
Lupin Completes Acquisition of Pharma Dynamics, South Africa
Date: Mar 16
February 2015
Lupin Receives US FDA Approval for Generic Lumigani® Ophthalmic Solution 0.03%.
Date: Feb 23
Lupin PR - Lupin Launches InspiraChamber Anti-Static Valved Holding Chamber_ Expands US Brands Portfolio
Date: Feb 18 Size: 111Kb
Lupin and Celon Announce Strategic Development and Licensing Agreement for Generic Advair Diskusi®
Date: Feb 17
Strong Margins, Robust Profits - Quarter III Results, FY 2015-2016
Date: Feb 03
Lupin Receives FDA Approval for Generic Vancocini® Capsules
Date: Feb 02
January 2015
Lupin launches Generic DIOVANi® Tablets
Date: Jan 06